Biomapas

Biomapas

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Biomapas is a private, revenue-generating contract research organization (CRO) and service provider specializing in clinical development, regulatory affairs, pharmacovigilance, and medical information. Rooted in the Baltics but operating pan-Europe and globally, the company leverages a hands-on, affiliate-based outsourcing model to deliver flexible, tailored support for pharmaceutical and biotech clients. Recent strategic moves, including the appointment of a new CEO with international experience and the acquisition of Delta PV in Turkey, signal an active growth phase aimed at building a global platform in life sciences services.

Drug DeliveryClinical Research

Technology Platform

Affiliate-Based Outsourcing model and operational systems for Pharmacovigilance (CSV), Medical Information, and GCP training.

Opportunities

The growing trend of outsourcing in pharma R&D, especially among mid-sized and small biotechs, creates sustained demand.
Expansion into emerging markets like Turkey via acquisition offers new growth avenues.
Increasing global regulatory complexity drives need for specialized Regulatory Affairs and Pharmacovigilance services.

Risk Factors

Operational risk related to service quality and regulatory compliance is paramount.
Success depends on talent retention in a competitive market and effective integration of acquisitions.
The company is exposed to macroeconomic fluctuations that could reduce biopharma R&D spending.

Competitive Landscape

Biomapas competes in a fragmented CRO and service market against large global CROs (IQVIA, ICON, PPD) and smaller niche players. Its differentiation is its mid-sized, pan-European, high-touch service model and affiliate-based outsourcing approach, targeting clients who seek agility and personalized partnership over the scale of large CROs.